Stay updated on Vertex Pharmaceuticals Press Releases
Sign up to get notified when there's something new on the Vertex Pharmaceuticals Press Releases page.

Latest updates to the Vertex Pharmaceuticals Press Releases page
- Check4 days agoChange DetectedThe page has updated its financial results announcement date and removed a previous clinical trial update.SummaryDifference4%
- Check11 days agoChange DetectedThe page now includes an announcement regarding the European Commission's approval of ALYFTREK, a new treatment for cystic fibrosis, while the previous announcement about FDA clearance for VX-407 has been removed.SummaryDifference5%
- Check18 days agoChange DetectedThe webpage has added significant updates regarding Vertex's positive data for Zimislecel in Type 1 Diabetes and a strategic agreement with Ono Pharmaceutical, while removing previous announcements about investor conferences and a positive opinion for KALYDECO.SummaryDifference8%
- Check26 days agoChange DetectedThe page has updated its content to include new information about CASGEVY presented at the 2025 EHA Congress, while removing a previous announcement regarding the European Commission's approval of the therapy.SummaryDifference5%
- Check33 days agoChange DetectedThe page has been updated to include new data on the benefits of ALYFTREK® presented at the European Cystic Fibrosis Conference, while previous financial results from Vertex have been removed.SummaryDifference4%
- Check54 days agoChange DetectedThe page has removed a significant announcement regarding Vertex's positive results from pivotal trials of a new cystic fibrosis treatment, while adding information about upcoming investor conferences.SummaryDifference3%
Stay in the know with updates to Vertex Pharmaceuticals Press Releases
Enter your email address, and we'll notify you when there's something new on the Vertex Pharmaceuticals Press Releases page.